# SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/simplify-1-a-phase-iii-randomized-trial-of-momelotinib-versus-ruxolitinib-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ruben A. Mesa,Jean‐Jacques Kiladjian,John Catalano,Timothy Devos,Miklós Egyed,Andrzei Hellmann,Donal P. McLornan,Kazuya Shimoda,Elliott F. Winton,Wei Deng,Ronald L. Dubowy,Julia D. Maltzman,Francisco Cervantes,Jason Gotlib |
| Citations | 375 |
| DOI | 10.1200/jco.2017.73.4418 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/6553796 |
| OpenAlex ID | https://openalex.org/W2754551124 |
| PMID | 28930494 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Wei Deng](https://scholariq.org/researchers/wei-deng/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)

## Paper topics

- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Eosinophilic Disorders and Syndromes](https://scholariq.org/topics/eosinophilic-disorders-and-syndromes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.